Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathogenic interactions between alcohol and hepatitis C.

Gyongyi Szabo1

  • 1Hepatology and Liver Center, Division of Gastroenterology, Department of Medicine, University of Massachusetts Medical School, 365 Plantation Street, Worcester, MA 01605, USA. gyongyi.szabo@umassmed.edu

Current Gastroenterology Reports
|January 18, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The impact of obesity on inflammatory cytokines and 90- and 180-day survival in patients with alcohol-associated hepatitis.

Clinical and translational gastroenterology·2026
Same author

Sparse CCA-Based Mediation Analysis with High-Dimensional Exposures and Mediators.

Bioinformatics (Oxford, England)·2026
Same author

Mean Arterial Pressure at Admission Predicts 28-day Mortality in Patients with Severe Alcohol-associated Hepatitis.

Clinical and translational gastroenterology·2026
Same author

Extended precision cut liver slice culture models liver regeneration and ductular reaction.

eGastroenterology·2026
Same author

EASL position paper on preclinical models of steatotic liver disease.

Journal of hepatology·2026
Same author

SIRPα Cleavage Is Associated with Inflammatory Response, Corticosteroid Nonresponse, and Worse Prognosis in Clinical and Preclinical Models of Alcohol-Associated Hepatitis.

The American journal of pathology·2026
Same journal

Management of Common Bile Duct Stones: Current Approaches and Evolving Endoscopic Strategies.

Current gastroenterology reports·2026
Same journal

Solitary Rectal Ulcer Syndrome Revisited: A Comprehensive Narrative Review.

Current gastroenterology reports·2026
Same journal

The Microbiome and Esophageal Disease: Where Are We Now?

Current gastroenterology reports·2026
Same journal

Fermented Durian Tempoyak as a Source of Probiotics for Colorectal Cancer Prevention through Gut Microbiome Modulation.

Current gastroenterology reports·2026
Same journal

A Practical Guide to Incorporating Novel Barrett's Screening/Surveillance Tools into Clinical Practice.

Current gastroenterology reports·2026
Same journal

The Role of Endoscopic Ultrasound in the Diagnosis and Management of Congenital Gastrointestinal and Pancreaticobiliary Conditions.

Current gastroenterology reports·2026
See all related articles

Alcohol and hepatitis C virus (HCV) infection accelerate liver disease progression. Combined, they impair immune responses and activate liver cells, increasing fibrosis risk in patients with chronic HCV infection.

Area of Science:

  • Hepatology
  • Immunology
  • Public Health

Background:

  • Alcohol abuse is a leading cause of liver disease in the US.
  • Chronic hepatitis C virus (HCV) infection is prevalent and often co-occurs with alcohol abuse.
  • The interaction between alcohol and HCV significantly impacts liver disease progression.

Purpose of the Study:

  • To investigate the combined effects of alcohol and HCV on liver disease.
  • To elucidate the mechanisms underlying accelerated liver fibrosis in co-infected patients.
  • To identify specific molecular pathways involved in alcohol-HCV interactions.

Main Methods:

  • Review of clinical studies on alcohol use and HCV fibrosis progression.
  • Analysis of experimental evidence on immune response interactions.

Related Experiment Videos

  • Identification of molecular pathways involving HCV core protein and alcohol in hepatocytes.

    • Main Results:

    • Alcohol is an independent risk factor for fibrosis progression in chronic HCV.
    • Combined alcohol and HCV exhibit additive inhibitory effects on antiviral immunity.
    • Specific pathways show alcohol and HCV core protein activating hepatocytes.
    • Inflammatory responses are implicated in both alcohol- and HCV-induced liver damage.

    Conclusions:

    • Alcohol and HCV synergistically accelerate liver disease progression.
    • Understanding these interactions is crucial for managing co-infected patients.
    • Further research into shared pathways may reveal therapeutic targets for liver disease.